1
|
Larrauffie A, Porcheron M, Pariente J, Wolfrum M, Bureau C, Zadro C, Otal P, Broue P, Sailler L, Moulis G, Maquet J, Goulabchand R. [Neurological trouble in a 68-year-old woman]. Rev Med Interne 2023; 44:529-532. [PMID: 37296033 DOI: 10.1016/j.revmed.2023.05.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Accepted: 05/23/2023] [Indexed: 06/12/2023]
Affiliation(s)
- A Larrauffie
- Service de médecine interne, CHU de Toulouse Purpan, place du Dr-Baylac, 31300 Toulouse, France.
| | - M Porcheron
- Service de neurologie, CHU de Toulouse Purpan, place du Dr-Baylac, 31300 Toulouse, France
| | - J Pariente
- Service de neurologie, CHU de Toulouse Purpan, place du Dr-Baylac, 31300 Toulouse, France
| | - M Wolfrum
- Service de neurologie, CHU de Toulouse Purpan, place du Dr-Baylac, 31300 Toulouse, France
| | - C Bureau
- Service d'hépatologie, CHU de Rangueil, 1, avenue du Professeur-Jean-Poulhès, 31400 Toulouse, France
| | - C Zadro
- Service de radiologie, CHU de Rangueil, 1, avenue du Professeur-Jean-Poulhès, 31400 Toulouse, France
| | - P Otal
- Service de radiologie, CHU de Rangueil, 1, avenue du Professeur-Jean-Poulhès, 31400 Toulouse, France
| | - P Broue
- Service d'hépatologie pédiatrique et maladies héréditaires du métabolisme, CHU de Toulouse Purpan, place du Dr-Baylac, 31300 Toulouse, France; Centre de référence des maladies héréditaires du métabolisme, hôpital des Enfants, CHU de Toulouse, 330, avenue de Grande-Bretagne, 31300 Toulouse, France
| | - L Sailler
- Service de médecine interne, CHU de Toulouse Purpan, place du Dr-Baylac, 31300 Toulouse, France
| | - G Moulis
- Service de médecine interne, CHU de Toulouse Purpan, place du Dr-Baylac, 31300 Toulouse, France
| | - J Maquet
- Service de médecine interne, CHU de Toulouse Purpan, place du Dr-Baylac, 31300 Toulouse, France; Centre de référence des maladies héréditaires du métabolisme, hôpital des Enfants, CHU de Toulouse, 330, avenue de Grande-Bretagne, 31300 Toulouse, France.
| | - R Goulabchand
- Service de médecine interne, hôpital universitaire Carémeau, CHU de Nîmes, place du Pr.-Robert-Debré, 30029 Nîmes cedex 9, France
| |
Collapse
|
2
|
Coustal C, Goulabchand R, Labauge P, Guilpain P, Carra-Dallière C, Januel E, Jeziorski E, Salle V, Viallard J, Boutboul D, Fieschi C, Gobert D, Aladjidi N, Rullier P, Graveleau J, Piel-Julian M, Suarez F, Neven B, Mahlaoui N, Ayrignac X. Atteintes neurologiques multifacettes des déficits en CTLA4 : étude observationnelle nationale. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.10.135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
3
|
Henry K, Deligny C, Witkowski Durand Viel P, Morel J, Guilpain P, Goulabchand R. [Infections in primary Sjögren's syndrome patients: "Real-life" study of 109 patients from Montpellier university hospital]. Rev Med Interne 2022; 43:696-702. [PMID: 36372632 DOI: 10.1016/j.revmed.2022.08.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Revised: 07/26/2022] [Accepted: 08/24/2022] [Indexed: 11/12/2022]
Abstract
INTRODUCTION Infections are responsible for a part of the overall mortality in primary Sjögren's syndrome patients (pSS). Our retrospective monocentric study aimed at describing infections reported in a population of pSS hospitalized patients, along with the characteristics of their disease. METHODS Patients with SS have been randomly selected from our hospital database claim, between 2009 and 2018. After careful analysis of their medical chart, only patients with pSS and fulfilling ACR/EULAR 2016 diagnosis criteria were included. We collected main clinical, biological and pathological characteristics of SS, along with all the reported infections during the follow-up. The characteristics of the disease were compared according to the presence of an infection in hospitalization. RESULTS In total, 109 pSS patients were included (93% of women, mean age 53.6±14.3 years, mean follow-up 8.2±8.4 years). Fifty-one percent had been exposed to hydroxychloroquine (HCQ). Seventy-eight infections were recorded in 47 (43%) patients. Twenty-five infections were recorded in hospitalization (5 in critical care) in 20 (18%) patients, whom leading causes were urinary tract (28%), pulmonary (24%), ENT (16%), and intestinal (12%) infections. pSS patients with infections in hospitalization were older, exhibited more hypocomplementemia, and were less exposed to HCQ. We found no difference in immunosuppressive treatments exposure. CONCLUSIONS The impact of HCQ exposure on infectious risk needs further investigations. Broad vaccination campaign and tight control of sicca syndrome could lead to a better control of infection risk.
Collapse
Affiliation(s)
- K Henry
- Département de médecine interne et maladies multi-organiques (MIMMO), CHU de Montpellier, hôpital Saint-Éloi, Montpellier, France; Service de médecine interne, CHU de Pierre-Zobda-Quitman, Fort-de-France, Martinique, France.
| | - C Deligny
- Service de médecine interne, CHU de Pierre-Zobda-Quitman, Fort-de-France, Martinique, France
| | - P Witkowski Durand Viel
- Département de médecine interne et maladies multi-organiques (MIMMO), CHU de Montpellier, hôpital Saint-Éloi, Montpellier, France; Université Montpellier, Montpellier, France
| | - J Morel
- Université Montpellier, Montpellier, France; Département de rhumatologie, CHU de Montpellier, hôpital Lapeyronie, Montpellier, France; Inserm, PhyMedExp, CNRS, université de Montpellier, Montpellier, France
| | - P Guilpain
- Département de médecine interne et maladies multi-organiques (MIMMO), CHU de Montpellier, hôpital Saint-Éloi, Montpellier, France; Université Montpellier, Montpellier, France; Inserm, IRMB, université Montpellier, Montpellier, France
| | - R Goulabchand
- Université Montpellier, Montpellier, France; Inserm, IRMB, université Montpellier, Montpellier, France; Médecine interne, CHU de Nîmes, Nîmes, France.
| |
Collapse
|
4
|
Robin C, Broner J, Holubar J, Bergeret B, Roger P, Arnaud E, Goulabchand R. Efficacité du Belimumab sur une atteinte cutanée sévère de connectivite mixte. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
5
|
Fantone M, Broner J, Dumain C, Fesler P, Arnaud E, Gaujoux-Viala C, Jeanjean L, Goulabchand R. Étude des évènements cortico-induits chez des patients atteints d’Uvéite Chronique Non Infectieuse. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Suzon B, Goulabchand R, Maria A, Najjari R, Le Quellec A, Bessis D, Louis-Sidney F, Guilpain P. Atteintes du tissu adipeux au cours des myopathies inflammatoires : revue systématique de la littérature augmentée de trois observations. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
7
|
Dumain C, Broner J, Arnaud E, Dewavrin E, Holubar J, Fantone M, De Wazieres B, Fesler P, Guilpain P, Roubille C, Goulabchand R. Tocilizumab, corticothérapie et risque iatrogène chez des patients atteints d’une artérite à cellules géantes : comment identifier les patients à risque en « vraie-vie » ? Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Roussotte M, Gerfaud-Valentin M, Lega J, Thibault T, Lobbes H, Goulabchand R, Cathébras P, Varron L, Dufour J, Deroux A, Le Guenno G, Compain C, Baudet A, Karkowski L, Perard L, Ebbo M, Hot A, Sève P. Traitement de la thrombopénie immunologique cliniquement significative secondaire au lupus érythémateux systémique : étude rétrospective de 90 patients en vie réelle. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
9
|
Dumain C, Partouche L, Goulabchand R. Une entérite aiguë. Rev Med Interne 2020; 41:138-139. [DOI: 10.1016/j.revmed.2019.06.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2019] [Accepted: 06/23/2019] [Indexed: 11/17/2022]
|
10
|
Roussotte M, Gerfaud-Valentin M, Lega J, Audia S, Ruivard M, Goulabchand R, Cathébras P, Varron L, Dufour J, Alban D, Le Guenno G, Compain C, Baudet A, Karkowski L, Perard L, Hot A, Sève P. Thrombopénie immunologique cliniquement significative secondaire au lupus érythémateux systémique : description d’une cohorte rétrospective de 74 cas. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
11
|
Goulabchand R, Castille E, Navucet S, Etchecopar-Etchart D, Maria A, Partouche L, Le Quellec A, Maréchal B, Le Bars E, Gabelle A, Menjot De Champfleur N, Guilpain P. IRM cérébrales au cours du syndrome de Gougerot–Sjögren : résultats préliminaires et aspects anatomo-cliniques. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
12
|
Suzon B, Rivière S, Rivet V, Goulabchand R, Altwegg R, Schiffmann A, Flori N, Senesse P, Le Quellec A, Guilpain P, Maria A. Nutrition parentérale dans la sclérodermie systémique : à propos de 6 patients atteints de pseudo occlusion intestinale suivis au CHU de Montpellier. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Castille E, Goulabchand R, Navucet S, Matos A, Etchecopar-Etchart D, Maria A, Gutierez L, Berr C, Le Quellec A, Menjot De Champfleur N, Gabelle A, Guilpain P. Atteintes neurocognitives du syndrome de Gougerot–Sjögren : évaluations standardisées des fonctions cognitives et de la qualité de vie. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
14
|
Rubenstein E, Maria A, Rigau V, Goulabchand R, Ferreira-Da Mota E, Amadou K, Rullier P, Pers Y, Combe B, Rivière S, Partouche L, Dufour S, Mahr A, Le Quellec A, Guilpain P. Pathologies malignes chez 36 patients présentant une artérite à cellules géantes et/ou une pseudo-polyarthrite rhizomélique : description et confrontation anatomo-clinique. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
15
|
Grossin D, Broner J, Arnaud E, Goulabchand R, Gris JC. [Acquired autoimmune haemophilia: Where is the place of rituximab in the treatment strategy? Reflection from a monocentric series of 8 patients and literature review]. Rev Med Interne 2019; 40:574-580. [PMID: 30904179 DOI: 10.1016/j.revmed.2019.02.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2018] [Revised: 02/14/2019] [Accepted: 02/24/2019] [Indexed: 10/27/2022]
Abstract
INTRODUCTION Autoimmune acquired haemophilia is a rare autoimmune disease. The purpose of immunosuppressive therapy is to stop the production of autoantibodies that inhibit clotting factors VIII or IX. A corticosteroids-cyclophosphamide combination is recommanded as first-line therapy. From our experience at the University Hospital of Nîmes, we discuss the place of rituximab in the therapeutic arsenal. METHODS We report a monocentric observational retrospective study. Our data are discussed in light of literature data, in particular cohorts EACH2 and SACHA. RESULTS Eight patients (7 with FVIII anibodies) were consecutively included from 2005. The average age was 68.5 years with a male predominance (62.5%). Bleeding manifestations were usually spontaneous and superficial. A pathology, mostly autoimmune or neoplastic, was associated in 5/8 patients. A "by-pass" haemostatic treatment was prescribed for 3/8 patients. Rituximab was prescribed for 5/8 patients, three times as first-line therapy, and always associated with corticosteroids. Three patients received a cyclophosphamid/cortisone combination, two were treated exclusively with oral corticosteroids. Remission was obtained in all patients, without subsequent relapse. The average time to obtain remission under rituximab (after the first injection) was 32.5 days (10-143). The results observed in our series of patients are consistent with the data from the literature. CONCLUSIONS Rituximab appears to be an effective and well-tolerated treatment for autoimmune acquired haemophilia. However, its place remains to be specified.
Collapse
Affiliation(s)
- D Grossin
- Service de médecine interne, CHU Nîmes, 30029 Nîmes, France.
| | - J Broner
- Service de médecine interne, CHU Nîmes, 30029 Nîmes, France
| | - E Arnaud
- Service de médecine interne, CHU Nîmes, 30029 Nîmes, France
| | - R Goulabchand
- Département de médecine interne maladies multi-organiques, CHU Saint-Éloi, Montpellier, France
| | - J C Gris
- Service d'hématologie, CHU Nîmes, 30029 Nîmes, France
| |
Collapse
|
16
|
Witkowski P, Guilpain P, Maria A, Goulabchand R, Mura F, Rivière S, Rullier P, Le Quellec A, Konaté A. Association polychondrite atrophiante, maladie de Crohn, spondylarthropathie B27, syndrome de Sweet et vascularite à ANCA. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
17
|
Rivet V, Goulabchand R, Juntas Morales R, Thouvenin Y, Maues De Paula A, Rivière S, Guilpain P, Le Quellec A. Radiculopathie chronique simulant une myosite : une entité à individualiser ? Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
18
|
Partouche L, Bourgier C, Maria A, Goulabchand R, Rivière S, Bessis D, Quere I, Morel J, Le Quellec A, Guilpain P. Traitement par radiothérapie des cancers chez les patients atteints de sclérodermie systémique. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
19
|
Fournier G, Morquin D, Goulabchand R, Tingaud C, de Boutray M. [Autochthonous dirofilariasis in the temporal muscle]. Med Mal Infect 2018; 48:424-426. [PMID: 29731192 DOI: 10.1016/j.medmal.2018.03.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2018] [Revised: 03/12/2018] [Accepted: 03/21/2018] [Indexed: 10/17/2022]
Affiliation(s)
- G Fournier
- Département d'ORL et chirurgie maxillo-faciale, hôpital Gui-de-Chauliac, 80, avenue Augustin-Fliche, 34295 Montpellier, France; Faculté de médecine, université de Montpellier, 641, avenue du Doyen-Gaston-Giraud, 34093 Montpellier, France.
| | - D Morquin
- Faculté de médecine, université de Montpellier, 641, avenue du Doyen-Gaston-Giraud, 34093 Montpellier, France; Département de maladie infectieuses et tropicales, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier, France
| | - R Goulabchand
- Faculté de médecine, université de Montpellier, 641, avenue du Doyen-Gaston-Giraud, 34093 Montpellier, France; Département de médecine interne, maladie multi-organiques de l'adulte, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier, France
| | - C Tingaud
- Service d'anatomopathologie, hôpital Gui-de-Chauliac, 80, avenue Augustin-Fliche, 34295 Montpellier, France
| | - M de Boutray
- Département d'ORL et chirurgie maxillo-faciale, hôpital Gui-de-Chauliac, 80, avenue Augustin-Fliche, 34295 Montpellier, France; Faculté de médecine, université de Montpellier, 641, avenue du Doyen-Gaston-Giraud, 34093 Montpellier, France
| |
Collapse
|
20
|
Goulabchand R, Dufour S, Murez T, Broner J, Rivière S, Guilpain P, Le Quellec A. [Systemic Bacillus Calmette-Guerin sepsis manifesting as autoimmunity, 17 months after an intravesical BCG-therapy]. Med Mal Infect 2017; 47:558-561. [PMID: 28943176 DOI: 10.1016/j.medmal.2017.05.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2017] [Accepted: 05/24/2017] [Indexed: 01/20/2023]
Affiliation(s)
- R Goulabchand
- Département de médecine interne maladies multi-organiques, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Faculté de médecine, université de Montpellier, 2, rue de l'École-de-médecine, 34060 Montpellier cedex 2, France.
| | - S Dufour
- Département de médecine interne maladies multi-organiques, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Faculté de médecine, université de Montpellier, 2, rue de l'École-de-médecine, 34060 Montpellier cedex 2, France; Département de maladies infectieuses et tropicales, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France
| | - T Murez
- Service d'urologie et de transplantation rénale, hôpital Lapeyronie, 371, avenue du doyen Gaston-Giraud, 34295 Montpellier cedex 5, France; Faculté de médecine, université de Montpellier, 2, rue de l'École-de-médecine, 34060 Montpellier cedex 2, France
| | - J Broner
- Département de médecine interne maladies multi-organiques, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Faculté de médecine, université de Montpellier, 2, rue de l'École-de-médecine, 34060 Montpellier cedex 2, France
| | - S Rivière
- Département de médecine interne maladies multi-organiques, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France
| | - P Guilpain
- Département de médecine interne maladies multi-organiques, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Faculté de médecine, université de Montpellier, 2, rue de l'École-de-médecine, 34060 Montpellier cedex 2, France
| | - A Le Quellec
- Département de médecine interne maladies multi-organiques, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Faculté de médecine, université de Montpellier, 2, rue de l'École-de-médecine, 34060 Montpellier cedex 2, France
| |
Collapse
|
21
|
Henneton P, Goulabchand R, Escal L, Cerutti D, Le Quellec A, Guilpain P. Une petite rate. Rev Med Interne 2017; 38:640-641. [DOI: 10.1016/j.revmed.2016.04.320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2016] [Accepted: 04/22/2016] [Indexed: 10/21/2022]
|
22
|
Dufour S, Rivière S, Goulabchand R, Konaté A, Guilpain P, Le Quellec A, Rullier P. Couverture vaccinale et facteurs influençant le comportement vaccinal des patients atteints de maladies auto-immunes et des professionnels de santé dans un service de médecine interne. Med Mal Infect 2017. [DOI: 10.1016/j.medmal.2017.03.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
23
|
Padern G, Maria A, Boudet A, Segondy M, Foulogne V, Goulabchand R, Rivière S, Guilpain P, Le Quellec A. Myopathie inflammatoire et méningo-encéphalite à HHV6 : un piège diagnostique potentiel. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
24
|
Goulabchand R, Hafidi A, Millet I, Morel J, Humbert S, Rivière S, Jorgensen C, Le Quellec A, Perrochia H, Guilpain P. Mastites associées au syndrome de Gougerot-Sjögren. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
25
|
Crickx E, Goulabchand R, Fieschi C, Galicier L, Coppo P, Delarue R, Moulis G, Michel M, Haioun C, Godeau B, Gaulard P, Mahevas M. Caractéristiques cliniques, évolution et prise en charge des cytopénies auto-immunes associées aux lymphomes T de type LAI : une étude multicentrique rétrospective comparative. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
26
|
Dufour S, Goulabchand R, Boclé H, Henneton P, Broner J, Rivière S, Guilpain P, Le Quellec A. Mycobactériose disséminée avec cytopénies auto-immunes après instillation vésicale de BCG : à propos d’un cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
27
|
Henneton P, Goulabchand R, Dufour S, Broner J, Rivière S, Lambotte O, Guilpain P, Le Quellec A. Syndrome d’activation macrophagique induit par l’EBV comportant des critères de gravité : efficacité du rituximab. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
28
|
Goulabchand R, Bony C, Maria A, Maumus M, Rivière S, Cerruti D, Guilhem A, Le Quellec A, Jorgensen C, Noël D, Guilpain P. Effet du sérum de patients sclérodermiques sur les caractéristiques phénotypiques et fonctionnelles des cellules souches mésenchymateuses. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
29
|
Maria A, Toupet K, Bony C, Goulabchand R, Le Quellec A, Jorgensen C, Noël D, Guilpain P. Bénéfices d’une injection de cellules souches mésenchymateuses dans la sclérodermie murine : effets comparés selon la compatibilité antigénique et l’origine tissulaire. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.034] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
30
|
Goulabchand R, Khellaf L, Costes V, Foulongne V, Riviere S, Forestier A, Le Quellec A, Guilpain P. Sclérodermie induite par le Cytomégalovirus (CMV) : rôle potentiel des lymphocytes NK. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
31
|
Goulabchand R, Mouterde G, Barnetche T, Morel J, Combe B. SAT0290 Effect of tnf antagonists on radiographic progression in psoriatic arthritis: Systematic review and meta-analysis of randomized controlled trials. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.3237] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
32
|
Goulabchand R, Aguilar-Martinez P, Dubois A, Rullier P, Le Quellec A, Konaté A. Anémie ferriprive inexpliquée et réfractaire au traitement oral : évoquer le syndrome IRIDA. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|